von Fliedner V, Carrel S, Morell A, Heumann D, Losa G, Hirt A, Jeannet M, Mach J P, Cruchaud A
Schweiz Med Wochenschr. 1981 Oct 10;111(41):1524-6.
111 patients with acute leukemia, including 29 children, were classified according to the surface markers and cytochemistry of their blasts. The acute leukemias were separated into two majors groups (lymphoid and non-lymphoid) depending on the presence or absence of specific lymphoid markers. On the basis of these criteria a correlation of 94% with the hematological diagnosis was obtained. Acute lymphoblastic leukemia (ALL) was divisible into three sub-groups: 11 cases expressing T-cell specific markers were classified as T-ALL and 33 cases expressing the common ALL antigen (CALLA) as c-ALL. 18 of the latter expressed an additional marker, DSA (Daudi surface antigen), splitting c-ALL cases in two subgroups. Cytochemistry of the cases lacking specific surface markers (n = 67) served to diagnose 41 acute myeloid leukemia (AML) cases and 8 monoblastic leukemias. The remaining 18 cases could not be classified. The presence of absence of HLD-DR (Ia) antigens served to subdivide AML into two major subgroups. The prognostic significance of these new diagnostic splits is under active study.
111例急性白血病患者(包括29名儿童),根据其原始细胞的表面标志物和细胞化学进行分类。根据特定淋巴样标志物的有无,将急性白血病分为两个主要组(淋巴样和非淋巴样)。基于这些标准,与血液学诊断的相关性达到了94%。急性淋巴细胞白血病(ALL)可分为三个亚组:11例表达T细胞特异性标志物的病例被分类为T-ALL,33例表达普通ALL抗原(CALLA)的病例为c-ALL。后者中有18例表达另一种标志物DSA(Daudi表面抗原),从而将c-ALL病例分为两个亚组。缺乏特异性表面标志物的病例(n = 67)的细胞化学检查有助于诊断41例急性髓细胞白血病(AML)和8例单核细胞白血病。其余18例无法分类。HLD-DR(Ia)抗原的有无有助于将AML进一步分为两个主要亚组。这些新的诊断分类的预后意义正在积极研究中。